A Monell Center study found that GLP-1 receptor agonists can effectively manage metabolic complications associated with Bardet-Biedl Syndrome, a rare genetic disorder characterized by early-onset obesity and cognitive impairments. The therapy significantly reduced food intake, caused weight loss, improved glucose tolerance, and normali...
A novel brain study uncovers the critical role of the HDAC5 enzyme in regulating gene expression and neuronal activity, which can trigger relapse in individuals with substance use disorders. The study highlights a new molecular target for developing novel treatments to reduce relapse risk.
A new study by RAND Corporation found that a specialized hospital service can significantly increase patients with opioid use disorder to start FDA-approved medication treatment. The trial showed that patients receiving the service were twice as likely to begin treatment and 72% more likely to link to post-discharge care.
Scientists at deCODE genetics identified associations between rare loss-of-function variants in HECTD2 and AKAP11 genes and the risk of bipolar disorder. The study suggests that these gene products may be promising targets for new treatments, as they interact with key cellular pathways involved in the disorder.
Researchers are testing a brain pacemaker to treat severe alcohol and opioid addiction, aiming to develop effective treatments and understand the brain mechanisms driving addiction disorders. The trial, known as Brain-PACER, uses deep brain stimulation to modulate brain activity and cravings.
The BD² Integrated Network, a collaborative model connecting bipolar disorder research and care, has expanded to 10 sites with four new institutions joining the network. The model combines traditional longitudinal cohort study and learning health network to improve outcomes for people with bipolar disorder.
Researchers have identified three cell types in the median raphe nucleus that control decisions on perseverance, exploration, and disengagement. These findings may help understand neuropsychiatric conditions such as OCD, autism, and major depressive disorder.
The March issues of The American Journal of Psychiatry and Psychiatric Services bring together new developments in treating depression, obsessive-compulsive disorder, and schizophrenia. These journal publications highlight the latest advancements in digital mental health innovations.
A recent study found that around 1 in 5 UK medical students consider dropping out due to mental health issues such as emotional exhaustion, insomnia, anxiety, and somatic symptoms. The shortage of doctors worldwide and the consequences of increased workload and chronic stress further contribute to this issue.
Researchers found that while lisdexamfetamine reduced binge episodes and improved appetite control in some patients, others experienced significant side effects and inconsistent efficacy. The study highlights the need for a more nuanced understanding of the drug's effects on patients with binge eating disorder.
Research suggests that people with OCD have similar delay discounting and risk tolerance as neurotypical individuals, challenging previous theories about the condition's impact on decision-making. The study's findings may lead to more individualized interventions for OCD treatment.
A free webinar by Brain & Behavior Research Foundation presents advancements in neurobiology of fight-or-flight responding and its targeting using noninvasive brain stimulation technologies. The discussion focuses on transcranial magnetic stimulation and focused ultrasound for developing new treatments.
Two studies suggest that psilocybin-assisted psychotherapy can improve mental health outcomes for patients with cancer and alcohol use disorder, reducing symptoms of anxiety, depression, and obsessive thoughts, while also promoting lasting personality changes.
Researchers from Juntendo University discovered a four-step neural pathway involved in response inhibition, involving visual processing, sensory integration, action control, and execution of inhibition. The study aims to develop targeted therapeutic strategies for conditions like ADHD and obsessive-compulsive disorder.
Researchers reported positive long-term results of bilateral capsulotomy for severe obsessive-compulsive disorder treatment, with high patient satisfaction even at 10 years. The study suggests MRgFUS capsulotomy may also be effective in managing other psychiatric diseases.
Researchers found that people with CTE and a family history of mental illness had an average score of 19 on aggression, compared to 17 for those without. A higher risk was seen among participants who died between 40-59 years old, indicating a potential link between genetic and environmental factors.
A new framework describes the balance between automatic responses and goal-directed control in habit formation. This imbalance can lead to everyday action slips and compulsive behaviors. The research provides a 'playbook' for behavior change, including strategies like implementation intentions and clinical interventions.
Behavioral therapies are proven to be the most effective treatment for Tourette syndrome, teaching patients how to manage tics using behavioral strategies. The therapies train patients to recognize early signs of an upcoming tic and implement strategies to reduce tic severity.
The COVID-19 pandemic triggers a significant increase in pediatric mental health challenges, with rising rates of anxiety, depression, OCD, and suicidality. Theoretical models such as intolerance of uncertainty offer valuable insights into the mechanisms behind these increases.
Researchers develop transcranial ultrasound stimulation (TUS) as a non-invasive therapy for brain-related issues, with potential for personalized treatments. A 'search and rescue tool' for the brain, TUS enables precise targeting of specific areas before treatment.
A new study found that psilocybin significantly reduced OCD-like behaviors and tic-like head-body twitches in genetically modified mice. The research provides hope for new treatments for these conditions and may offer benefits for patients who have not responded to current therapies.
Scientists have developed novel magnetic nanodiscs that can remotely stimulate parts of the brain, potentially treating neurological and psychiatric conditions. The devices were injected into specific brain regions in mice and triggered by a weak electromagnet, demonstrating precise control over neural activity.
A novel sensory CBT treatment strategy has demonstrated its potential in a pre-clinical study, improving participants' ability to discard items and reducing anxiety and distress. The study found that imagery rescripting was more effective than other techniques in promoting discarding behavior and reducing negative emotions.
A new study finds that preventive health technologies can support healthy routines but also lead to compulsive usage, ultimately harming users. Consumers' experiences with these technologies vary, from increased engagement to reduced interest and obsessive behavior.
A recent study found that only 43.8% of US jails provide medication for opioid use disorder, with most citing lack of licensed staff as a major barrier. The majority of jails (70.1%) offer substance use disorder treatment or recovery support, but access remains limited due to cost and staffing challenges.
A new study reveals how psilocybin alters brain connectivity to alleviate symptoms of body dysmorphic disorder, potentially aiding treatment. Psilocybin strengthens neural connections between executive functions and emotionally salient stimuli, leading to improved BDD symptoms.
Researchers report significant strides in enhancing early diagnosis of bipolar disorder in adolescents by combining multimodal MRI with behavioral assessments. This approach reveals specific changes in brain networks signaling early-stage bipolar disorder, potentially leading to better and more personalized treatments. The study's find...
Laura Cabrera's research aims to develop a patient-centered decision aid to help guide patients, providers, and caregivers navigate neurotechnology treatments like deep brain stimulation. The project seeks to enhance shared decision-making processes, ensuring that treatments align with individual values and preferences.
A team of researchers has developed a new way to study disorder in superconductors using terahertz pulses of light. They observed that the disorder in superconducting transport was significantly lower than previously thought, with stability up to 70% of the transition temperature.
Research suggests that diagnostic labels for people experiencing mild mental health issues can increase empathy and support, but also undermine perceived agency and expectations of overcoming problems. This study found varying responses depending on the disorder, with some conditions eliciting high empathy and accommodation support.
Researchers found that intensive outpatient group- and family-based CBT that integrates telehealth can lead to significant improvements in pediatric anxiety and OCD symptoms. The hybrid model showed lasting gains for children even after treatment ended, with most families continuing to meet with clinicians after discharge.
A neuroimaging study reveals extensive changes in brain structure among young people with conduct disorder, including a smaller cerebral cortex and lower volume in several subcortical regions. The findings suggest a link between brain structure and symptoms of conduct disorder.
A recent study identified a novel biomarker to predict clinical status in individuals with treatment-resistant OCD undergoing deep brain stimulation therapy. The biomarker targets pathological avoidance behaviors and has shown promising results in improving symptom management.
A study published in Nature Communications has identified a neurological mechanism underlying anorexia nervosa and found a possible cure using donepezil, a medication increasing acetylcholine levels. Ongoing studies show positive results for patients with severe anorexia nervosa treated with low doses of donepezil.
A study published in Gut reveals that specific bacteria in the gut are involved in compulsive eating and obesity, with a beneficial bacterium called Blautia showing protective effects. The research also highlights the role of microRNAs in food addiction and suggests potential new treatments involving beneficial bacteria and dietary sup...
A new study by CAMH found that nearly 75% of young Ontarians with a psychotic disorder had at least one mental health service visit within three years prior to their first diagnosis. The study suggests that youth with a psychotic disorder are nearly four times as likely to have a previous mental health-related hospital admission.
A team of researchers discovered a group of neurons in the brain associated with compulsive eating and food craving. The discovery found that activation of these cells triggered vigorous foraging behavior in mice, even when they were already full.
Researchers at EPFL have developed a novel non-invasive technique to target deep brain regions involved in neurological disorders. By applying low-level electrical stimulation on the scalp, they can selectively stimulate key brain regions without invasive procedures.
A five-year study found that 61% of individuals still experienced binge-eating disorder 2.5 years after their initial diagnosis, and 45% at 5 years. Most participants showed improvements, but relapse was common among those in remission.
A new study shows that psilocybin initiates a pattern of hyperconnectivity in the brain linked to the ego-modifying effects and feelings of oceanic boundlessness. The findings provide insights into how the brain works on psychedelic drugs and their potential use to treat psychiatric disorders.
SourceElsevier·JournalBiological Psychiatry Cognitive Neuroscience and Neuroimaging·TypeImaging analysis·DateMay 23, 2024
A recent meta-analysis found that one in four patients with insulin-dependent diabetes exhibit eating disorder symptoms, including binge eating and food restriction. Intentional insulin omission is a unique form of disordered eating where insulin doses are restricted or skipped due to fears of weight gain.
Researchers used CRISPR/Cas9 DNA editing to insert genetic mutations found in humans with Tourette disorder into mouse embryos, creating a model to study the neurobiology and test new medications. The mice exhibited repetitive motor behaviors and sensorimotor gating deficits, similar to those seen in humans with the disorder.
A new study published by the University of Bath found that adolescents are more vulnerable to cannabis use disorder than adults, despite using cannabis less frequently. The study showed that adolescents reported greater negative impacts on daily functioning and symptoms of cannabis use disorder.
Researchers found a genetic link between higher circulating levels of arachidonic acid and lower risk for bipolar disorder. The study suggests that altering arachidonic acid synthesis pathways may reduce bipolar disorder risk, particularly in those with compromised pathways.
Researchers identified a genetic link between higher levels of arachidonic acid and lower risk of bipolar disorder. Arachidonic acid, found in meat, seafood, and human milk, may hold potential for lifestyle or dietary interventions to prevent or treat the condition.
A large study found that people with opioid use disorder were less likely to receive palliative care and died at younger ages due to causes unrelated to their condition. The lack of access to palliative care was attributed to challenges in accessing social support, finances, and stable housing.
The review highlights the clinical applications of MRgFUS in treating essential tremor, Parkinson's disease, and other intracranial disorders. High-intensity FUS is found to be a safe and effective treatment for these conditions, with potential benefits including non-invasive therapy and real-time temperature monitoring.
A new study from Mass General Brigham used deep brain stimulation to identify specific brain circuits associated with different disorders, such as Parkinson's disease and obsessive compulsive disorder. The researchers were able to apply these findings to fine-tune DBS treatments and demonstrate preliminary improved results in three cases.
A team of researchers used deep brain stimulation to localize disrupted neural pathways in patients with Parkinson's disease, dystonia, OCD, and Tourette's syndrome. The study identified specific brain circuits associated with each disorder, revealing overlapping malfunctions that suggest a complex network of brain dysfunctions.
The dictionary, based on first-person accounts, highlights the power of language in shaping understanding of mental health. It recommends empowering metaphors for use in public discourse to convey control, positivity, and empowerment.
A new approach to sensor manufacturing allows for minimally-invasive, high-resolution recording of deep brain activity, enabling the analysis of specific brain signals. The technology has the potential to enhance physicians' ability to acquire and understand brain signals at a higher resolution.
A recent study found that people with obsessive-compulsive disorder (OCD) have an increased risk of death from both natural and unnatural causes. The researchers suggest that better surveillance, prevention, and early intervention strategies should be implemented to reduce the risk of fatal outcomes in individuals with OCD.
A recent study by University of Cincinnati Blue Ash students found that individuals with clinically significant levels of OCD are more prone to problematic smartphone use. The research also highlighted the impact of fear of missing out, boredom proneness, and inhibitory anxiety on the relationship between OCD and PSU.
Researchers from Zhejiang University School of Medicine have revealed key connections between clinical characteristics, neuroimaging, and treatment in obsessive-compulsive disorder (OCD). The study found that about 13-36% of patients show poor insight, linked to more severe symptoms and poorer treatment outcomes.
Researchers have discovered a brain circuit that mediates panic disorder, consisting of specialized neurons that send and receive the neuropeptide PACAP. Inhibiting PACAP signaling reduces panic symptoms, offering promising findings for future treatments.
Scientists at Kyoto University have discovered two gene clusters associated with anxiety disorders that have distinct spatial and temporal expression patterns and functional profiles within the human brain. These findings provide new insights into the underlying causes of ADs and may lead to novel therapeutic strategies.
A new study finds that exposure and response prevention (EX/RP) therapy for OCD improves cognitive control by strengthening connections between brain networks. This breakthrough sheds light on the mechanisms underlying EX/RP's effectiveness in treating OCD, paving the way for targeted therapies.
SourceElsevier·JournalBiological Psychiatry Cognitive Neuroscience and Neuroimaging·TypeImaging analysis·DateNov 29, 2023
A patient at OHSU received a single stimulator implanted in the brain to effectively control two life-altering conditions: seizures caused by epilepsy and compulsive behavior caused by obsessive-compulsive disorder. The treatment, known as responsive neurostimulation system (RNS), has dramatically improved Pearson's quality of life.
Researchers developed a new way to diagnose bipolar disorder using a simple blood test that can identify up to 30% of patients. The test, combined with digital mental health assessments, can differentiate between major depressive disorder and bipolar disorder.
Previous studies suggest that psychedelics can induce an altered state of consciousness leading to new thought patterns, which is promising in treating OCD. Research analyzing the experience of past users found dissipation of obsessive thoughts, reduced anxiety, and increased acceptance of OCD symptoms.